PDCD1 and neoplasm: Indeed, a progressive Dnmt3a-mediated de novo methylation has been observed in murine antigen-specific CD8 T cells that underwent exhaustion via repression of key genes implicated in the effector function, the proliferation, metabolism, and tumor recruitment of immune cells, impairing T cell expansion and clonal diversity under treatment with anti-PD-1 [148].